Insider Trading Activity Dova Pharmaceuticals (NASDAQ:DOVA) – Director Bought 120,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Dova Pharmaceuticals (NASDAQ:DOVA)

Paul B Manning , Director of Dova Pharmaceuticals (NASDAQ:DOVA) reportedly Bought 120,000 shares of the company’s stock at an average price of 26.17 for a total transaction amount of $3,140,400.00 SEC Form

Insider Trading History For Dova Pharmaceuticals (NASDAQ:DOVA)

  • On 7/5/2017 Steven M Goldman, Director, bought 72,000 with an average share price of $17.94 per share and the total transaction amounting to $1,291,680.00.
  • On 7/5/2017 Lee F Md Phd Allen, Insider, bought 3,500 with an average share price of $17.00 per share and the total transaction amounting to $59,500.00.
  • On 7/5/2017 Kevin Laliberte, VP, bought 6,200 with an average share price of $17.00 per share and the total transaction amounting to $105,400.00.
  • On 7/5/2017 Alex Sapir, CEO, bought 20,100 with an average share price of $17.00 per share and the total transaction amounting to $341,700.00.
  • On 8/15/2017 Steven M Goldman, Director, bought 20,169 with an average share price of $22.23 per share and the total transaction amounting to $448,356.87.
  • On 8/16/2017 Paul B Manning, Director, bought 25,870 with an average share price of $22.30 per share and the total transaction amounting to $576,901.00.
  • On 6/5/2018 Paul B Manning, Director, bought 120,000 with an average share price of $26.17 per share and the total transaction amounting to $3,140,400.00.

    • Analyst Ratings History For Dova Pharmaceuticals (NASDAQ:DOVA)

    • On 7/24/2017 JPMorgan Chase & Co. Initiated Coverage of rating Overweight ➝ Overweight with a price target of $35.00
    • On 9/26/2017 Leerink Swann Upgraded rating Market Perform ➝ Outperform with a price target of $32.00
    • On 11/28/2017 Jefferies Group Boost Price Target of rating Buy with a price target of $33.00
    • On 3/23/2018 Evercore ISI Initiated Coverage of rating In ➝ line with a price target of $29.00
    • On 4/26/2018 LADENBURG THALM/SH SH Initiated Coverage of rating Buy

    Recent Trading Activity for Dova Pharmaceuticals (NASDAQ:DOVA)
    Shares of Dova Pharmaceuticals closed the previous trading session at with shares trading hands.